Price
$1.36
Increased by 0.00%
Dollar Volume
4.68 M
ADR%
9.54
Earnings Report Date (estimate)
May 8, 23 (-0.33)
Market Cap.
498.10 M
Shares Float
257.63 M
Shares Outstanding
366.25 M
Beta
1.10
Price / Earnings
-0.84
BPR
3.98
20D Range
0.99 1.50
50D Range
0.99 1.92
200D Range
0.99 4.86
  • Quarterly Earnings
  • Annual Earnings
Reported Date EPSChange YoY EstimateSurprise
Mar 15, 23 -0.50
Decreased by -516.67%
-0.27
Decreased by -315.50%
Nov 8, 22 -0.44
Decreased by -300.00%
-0.21
Decreased by -521.54%
Aug 9, 22 -0.34
Decreased by -780.00%
-0.26
Decreased by -118.34%
May 10, 22 -0.37
Increased by +65.74%
-0.30
Decreased by -77.78%
Mar 1, 22 0.12
Increased by +127.27%
-0.20
Increased by +800.00%
Nov 8, 21 -0.11
Increased by +73.17%
-0.15
Increased by +177.78%
Aug 5, 21 0.05
Increased by +108.93%
-0.13
Increased by +1.07 K%
May 6, 21 -1.08
Decreased by -92.86%
-0.02
Decreased by -265.00 K%
  • Quarterly Financials
  • Annual Financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 22 71.13 M
Increased by +48.60%
-161.40 M
Decreased by -389.91%
Decreased by -226.90%
Decreased by -229.68%
Jun 30, 22 65.21 M
Increased by +24.64%
-110.01 M
Decreased by -815.25%
Decreased by -168.71%
Decreased by -673.85%
Mar 31, 22 57.71 M
Decreased by -67.37%
-107.31 M
Increased by +63.16%
Decreased by -185.94%
Decreased by -12.91%
Dec 31, 21 64.78 M
Decreased by -18.77%
37.84 M
Increased by +134.52%
Increased by +58.42%
Increased by +142.50%
Sep 30, 21 47.87 M
Increased by +39.72%
-32.94 M
Decreased by -42.27%
Decreased by -68.83%
Decreased by -1.82%
Jun 30, 21 52.32 M
Increased by +74.36%
15.38 M
Increased by +113.93%
Increased by +29.40%
Increased by +107.99%
Mar 31, 21 176.86 M
Increased by +507.14%
-291.25 M
Decreased by -231.55%
Decreased by -164.68%
Increased by +45.39%
Dec 31, 20 79.74 M
Increased by +96.72%
-109.62 M
Decreased by -38.98%
Decreased by -137.46%
Increased by +29.35%
  • Top 20 ETF Stock Exposure
  • Top 20 Institutional Holders
  • Top 20 Mutual Fund Holders
Rank ETF Shares Market Value Weight % in ETF
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY

Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. It offers its products under the Biossance, Pipette, Purecane, Terasana, Costa Brazil, OLIKA, Rose Inc., and JVN brand names. The company has a collaboration agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California.